Anti-Inflammatory Drugs Global Market Report 2026

Description

Anti-inflammatory drugs are medications that reduce inflammation, pain, fever, and swelling by modulating the body's natural inflammatory response. They act by inhibiting the production or activity of chemical messengers such as prostaglandins, leukotrienes, and cytokines, which play key roles in initiating and sustaining inflammation.

The main classes of anti-inflammatory drugs include steroids, nonsteroidal anti-inflammatory drugs (NSAIDs), biologics and biosimilars, and others. Steroids are anti-inflammatory agents that mimic natural hormones and are used to treat conditions such as asthma, arthritis, and allergies. They can be administered via parenteral, oral, topical, and inhalation routes. These drugs are applied in a variety of conditions, including autoimmune diseases, respiratory disorders, and others, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies.

Tariffs have increased the cost of APIs, biologics, and formulation excipients in the anti-inflammatory drugs market, raising production and distribution expenses for both NSAIDs and biologic therapies. Biologics, biosimilars, and injectable anti-inflammatory drugs are most impacted, particularly in North America and Europe, which rely heavily on global pharmaceutical supply chains. On the positive side, tariffs are driving local manufacturing investments and biosimilar development, enhancing long-term market competitiveness and supply stability.

The anti-inflammatory drugs market research report is one of a series of new reports from The Business Research Company that provides anti-inflammatory drugs market statistics, including anti-inflammatory drugs industry global market size, regional shares, competitors with a anti-inflammatory drugs market share, detailed anti-inflammatory drugs market segments, market trends and opportunities, and any further data you may need to thrive in the anti-inflammatory drugs industry. This anti-inflammatory drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The anti-inflammatory drugs market size has grown rapidly in recent years. It will grow from $152.08 billion in 2025 to $168.74 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to arthritis prevalence, nsaid usage, hospital prescribing, autoimmune disease burden, steroid therapy adoption.

The anti-inflammatory drugs market size is expected to see rapid growth in the next few years. It will grow to $252.87 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to biologic innovation, biosimilar penetration, aging population, autoimmune disease growth, precision medicine adoption. Major trends in the forecast period include growing use of biologics and biosimilars, expansion of chronic inflammatory disease treatment, shift toward targeted anti-inflammatory therapies, growth of topical and localized formulations, increased focus on long-term safety.

The rising prevalence of arthritis is expected to drive the growth of the anti-inflammatory drugs market in the coming years. Arthritis is the inflammation of one or more joints, causing pain, swelling, and stiffness that often worsens with age. The increasing incidence of arthritis is primarily linked to aging populations, as natural wear and tear on joints over time raises the likelihood of developing the condition. Anti-inflammatory drugs help manage arthritis by reducing joint inflammation and pain, enabling patients to maintain mobility, perform daily activities more easily, and improve overall quality of life. For example, in July 2024, Restored CDC, a US-based nonprofit health information organization, reported that an estimated 21.2% of adults aged 18 and older in the US were diagnosed with arthritis in 2023. Therefore, the rising prevalence of arthritis is fueling growth in the anti-inflammatory drugs market.

Leading companies in the anti-inflammatory drugs market are focusing on innovative solutions, such as next-generation corticosteroid alternatives, to meet the growing demand for safer long-term anti-inflammatory therapies. Next-generation corticosteroid alternatives are designed to retain glucocorticoid anti-inflammatory effects while minimizing adverse outcomes commonly associated with traditional steroids, including bone loss, growth suppression, and weight gain. For instance, in October 2023, Santhera Pharmaceuticals, a Switzerland-based specialty pharmaceutical company, received FDA approval for AGAMREE (vamorolone). AGAMREE is an oral dissociative steroid that delivers anti-inflammatory activity with reduced steroid-related side effects by selectively modulating glucocorticoid receptor pathways and stabilizing cell membranes. Compared to traditional corticosteroids like prednisone and deflazacort, it offers a more favorable safety profile while maintaining therapeutic benefits and is used to manage chronic muscle inflammation in children aged two years and older with Duchenne muscular dystrophy.

In October 2023, Amgen, a US-based biopharmaceutical company, acquired Horizon Therapeutics for approximately $27.8 billion. Through this acquisition, Amgen aims to strengthen its portfolio in autoimmune and severe inflammatory diseases by integrating Horizon's therapies, including TEPEZZA, KRYSTEXXA, and UPLIZNA, and expanding its presence in the treatment of rare and chronic inflammatory conditions. Horizon Therapeutics is an Ireland-based biopharmaceutical company specializing in therapies for rare inflammatory and autoimmune diseases.

Major companies operating in the anti-inflammatory drugs market are Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

North America was the largest region in the anti-inflammatory drugs market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the anti-inflammatory drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the anti-inflammatory drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The anti-inflammatory drugs market consists of sales of immunosuppressants, COX-2 inhibitors, interleukin inhibitors, and TNF-alpha inhibitors. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Anti-Inflammatory Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses anti-inflammatory drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for anti-inflammatory drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The anti-inflammatory drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Drug Class: Steroids; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Biologics And Biosimilars; Other Drug Classes
2) By Route of Administration: Parenteral; Oral; Topical; Inhalation
3) By Applications: Autoimmune Diseases; Respiratory Diseases; Other Diseases
4) By Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Pharmacy
Subsegments:
1) By Steroids: Corticosteroids; Mineralocorticoids
2) By Nonsteroidal Anti-Inflammatory Drugs (NSAIDs): Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Selective Cyclooxygenase-2 (COX-2) Inhibitors
3) By Biologics And Biosimilars: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin (IL) Inhibitors; Janus Kinase (JAK) Inhibitors; Other Biologics And Biosimilars
4) By Other Drug Classes: Disease-Modifying Anti-Rheumatic Drugs (DMARDs); Immunosuppressants
Companies Mentioned: Merck & Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; Gilead Sciences Inc.; Amgen Inc.; Regeneron Pharmaceuticals Inc.; Biogen Inc.; Vertex Pharmaceuticals Inc.; UCB S.A.; Sun Pharmaceutical Industries Ltd.; Aurobindo Pharma Limited; Dr. Reddy's Laboratories; Cipla Limited; Cadila Pharmaceuticals; Samsung Bioepis; Lupin Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: PH4MAIDN03_G26Q1

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Anti-Inflammatory Drugs Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Anti-Inflammatory Drugs Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Anti-Inflammatory Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Anti-Inflammatory Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Industry 4.0 & Intelligent Manufacturing
- 4.1.3 Artificial Intelligence & Autonomous Intelligence
- 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.5 Sustainability, Climate Tech & Circular Economy
4.2. Major Trends
- 4.2.1 Growing Use Of Biologics And Biosimilars
- 4.2.2 Expansion Of Chronic Inflammatory Disease Treatment
- 4.2.3 Shift Toward Targeted Anti-Inflammatory Therapies
- 4.2.4 Growth Of Topical And Localized Formulations
- 4.2.5 Increased Focus On Long-Term Safety

5. Anti-Inflammatory Drugs Market Analysis Of End Use Industries

5.1 Hospitals
5.2 Clinics
5.3 Specialty Rheumatology Centers
5.4 Retail Pharmacies
5.5 Online Pharmacies

6. Anti-Inflammatory Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Anti-Inflammatory Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Anti-Inflammatory Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Anti-Inflammatory Drugs Market Size, Comparisons And Growth Rate Analysis
7.3. Global Anti-Inflammatory Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Anti-Inflammatory Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Anti-Inflammatory Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Anti-Inflammatory Drugs Market Segmentation

9.1. Global Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Steroids, Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Biologics And Biosimilars, Other Drug Classes
9.2. Global Anti-Inflammatory Drugs Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Parenteral, Oral, Topical, Inhalation
9.3. Global Anti-Inflammatory Drugs Market, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Autoimmune Diseases, Respiratory Diseases, Other Diseases
9.4. Global Anti-Inflammatory Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
9.5. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Steroids, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Corticosteroids, Mineralocorticoids
9.6. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Non-Selective Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Selective Cyclooxygenase-2 (COX-2) Inhibitors
9.7. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Biologics And Biosimilars, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Tumor Necrosis Factor (TNF) Inhibitors, Interleukin (IL) Inhibitors, Janus Kinase (JAK) Inhibitors, Other Biologics And Biosimilars
9.8. Global Anti-Inflammatory Drugs Market, Sub-Segmentation Of Other Drug Classes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Disease-Modifying Anti-Rheumatic Drugs (DMARDs), Immunosuppressants

10. Anti-Inflammatory Drugs Market Regional And Country Analysis

10.1. Global Anti-Inflammatory Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Anti-Inflammatory Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Anti-Inflammatory Drugs Market

11.1. Asia-Pacific Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Anti-Inflammatory Drugs Market

12.1. China Anti-Inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Anti-Inflammatory Drugs Market

13.1. India Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Anti-Inflammatory Drugs Market

14.1. Japan Anti-Inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Anti-Inflammatory Drugs Market

15.1. Australia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Anti-Inflammatory Drugs Market

16.1. Indonesia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Anti-Inflammatory Drugs Market

17.1. South Korea Anti-Inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Anti-Inflammatory Drugs Market

18.1. Taiwan Anti-Inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Anti-Inflammatory Drugs Market

19.1. South East Asia Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Anti-Inflammatory Drugs Market

20.1. Western Europe Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Anti-Inflammatory Drugs Market

21.1. UK Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Anti-Inflammatory Drugs Market

22.1. Germany Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Anti-Inflammatory Drugs Market

23.1. France Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Anti-Inflammatory Drugs Market

24.1. Italy Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Anti-Inflammatory Drugs Market

25.1. Spain Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Anti-Inflammatory Drugs Market

26.1. Eastern Europe Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Anti-Inflammatory Drugs Market

27.1. Russia Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Anti-Inflammatory Drugs Market

28.1. North America Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Anti-Inflammatory Drugs Market

29.1. USA Anti-Inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Anti-Inflammatory Drugs Market

30.1. Canada Anti-Inflammatory Drugs Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Anti-Inflammatory Drugs Market

31.1. South America Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Anti-Inflammatory Drugs Market

32.1. Brazil Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Anti-Inflammatory Drugs Market

33.1. Middle East Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Anti-Inflammatory Drugs Market

34.1. Africa Anti-Inflammatory Drugs Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Anti-Inflammatory Drugs Market, Segmentation By Drug Class, Segmentation By Route of Administration, Segmentation By Applications, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Anti-Inflammatory Drugs Market Regulatory and Investment Landscape

36. Anti-Inflammatory Drugs Market Competitive Landscape And Company Profiles

36.1. Anti-Inflammatory Drugs Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Anti-Inflammatory Drugs Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Anti-Inflammatory Drugs Market Company Profiles
- 36.3.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

37. Anti-Inflammatory Drugs Market Other Major And Innovative Companies

Bristol-Myers Squibb Company, AstraZeneca plc, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Biogen Inc., Vertex Pharmaceuticals Inc., UCB S.A., Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Cipla Limited, Cadila Pharmaceuticals, Samsung Bioepis, Lupin Limited

38. Global Anti-Inflammatory Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Anti-Inflammatory Drugs Market

40. Anti-Inflammatory Drugs Market High Potential Countries, Segments and Strategies

40.1 Anti-Inflammatory Drugs Market In 2030 - Countries Offering Most New Opportunities
40.2 Anti-Inflammatory Drugs Market In 2030 - Segments Offering Most New Opportunities
40.3 Anti-Inflammatory Drugs Market In 2030 - Growth Strategies
- 40.3.1 Market Trend Based Strategies
- 40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations
41.2. Currencies
41.3. Historic And Forecast Inflation Rates
41.4. Research Inquiries
41.5. The Business Research Company
41.6. Copyright And Disclaimer